Feb 6, 2026
Trump ex program and Zepbound
initiative secured agreements with and to sharply reduce cash and government prices for drugs, including Lilly’s tirzepatide (Zepbound), while expanding limited and access under new terms; the changes...
Your fact-checks will appear here
The Trump administration’s TrumpRx initiative to reduce prices for GLP-1 drugs